Theriva Biologics, Inc. (TOVX)
$0.22+0.00%Close
SELLRECOVERY · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $10M
- Beta
- 1.15
- P/E (TTM)
- -0.33
- Short % float
- 4.88%
- Days to cover
- 3.9
- SI change
- +7.7%
- 1W
- -4.35%
- 1M
- -12.00%
- vs SPY 1W
- -4.77%
- vs SPY 1M
- -14.06%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on TOVX?
- LOPJLB’s latest quantitative signal on Theriva Biologics, Inc. (TOVX) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is TOVX in?
- Theriva Biologics, Inc. (TOVX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Theriva Biologics, Inc. (TOVX) do?
- Theriva Biologics Inc. is a clinical-stage biotechnology firm dedicated to developing novel treatments for conditions with significant unmet medical needs. The company's pipeline features several promising candidates, including SYN-004, which is engineered to break down commonly used intravenous beta-lactam antibiotics in the gastrointestinal tract. This degradation aims to avert microbiome dam…